Non-steroidal Anti-inflammatory Drugs Market by Disease Indication (Arthritis, Migraine, Ophthalmic Diseases), Drugs (Over-the-counter Drugs, Prescription), Route of Administration, Distribution Channel - Global Forecast 2024-2030

Non-steroidal Anti-inflammatory Drugs Market by Disease Indication (Arthritis, Migraine, Ophthalmic Diseases), Drugs (Over-the-counter Drugs, Prescription), Route of Administration, Distribution Channel - Global Forecast 2024-2030

The Non-steroidal Anti-inflammatory Drugs Market size was estimated at USD 21.71 billion in 2023 and expected to reach USD 23.24 billion in 2024, at a CAGR 7.53% to reach USD 36.10 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Non-steroidal Anti-inflammatory Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Non-steroidal Anti-inflammatory Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Non-steroidal Anti-inflammatory Drugs Market, highlighting leading vendors and their innovative profiles. These include Apotex Inc., Assertio Therapeutics, Inc., AstraZeneca PLC, Bayer AG, Boehringer Ingelheim International GmbH, Eli Lilly and Company, GlaxoSmithKline PLC, Iroko Pharmaceuticals Inc., Johnson & Johnson Services, Inc., Merck & Co., Inc., Perrigo Company PLC, Pfizer Inc., Reckitt Benckiser Group PLC, Sanofi S.A., and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Non-steroidal Anti-inflammatory Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

Disease Indication

Arthritis

Migraine

Ophthalmic Diseases
Drugs

Over-the-counter Drugs
Aspirin (Bufferin, Bayer, & Excedrin)
Ibuprofen (Advil, Motrin, Nuprin)
Ketoprofen (Actron, Orudis)
Naproxen (Aleve)

Prescription
Daypro
Indocin
Lodine
Naprosyn
Relafen
Vimovo
Voltaren
Route of Administration

Oral

Parenteral
Distribution Channel

Drug Store

Hospital Pharmacy

Online Pharmacy

Retail Pharmacy
Region

Americas
Argentina
Brazil
Canada
Mexico
United States

California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas

Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam

Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Non-steroidal Anti-inflammatory Drugs Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Non-steroidal Anti-inflammatory Drugs Market?
3. What are the technology trends and regulatory frameworks in the Non-steroidal Anti-inflammatory Drugs Market?
4. What is the market share of the leading vendors in the Non-steroidal Anti-inflammatory Drugs Market?
5. Which modes and strategic moves are suitable for entering the Non-steroidal Anti-inflammatory Drugs Market?

Note: PDF & Excel + Online Access - 1 Year